Abstract:Alzheimer’s disease (AD), a prevalent neurodegenerative disorder, presents significant challenges in drug development due to its multifactorial nature. The AlzyFinder Platform presented here addresses this by providing a comprehensive, free web-based tool for ligand-based virtual screening and network pharmacology, specifically targeting over 85 key proteins implicated in AD. Utilizing advanced machine learning models, AlzyFinder facilitates the identification of potential multitarget ligands and their systemic therapeutic impacts. The platform's user-friendly interface allows for various input methods, including SMILES format and a molecular editor. AlzyFinder outputs interaction data in multiple formats (tables, heatmaps, and interactive Ligand-Protein Interaction networks) enhancing the visualization and analysis of drug-protein interactions. Key machine learning models employed by AlzyFinder, were meticulously trained and validated using robust methodologies, ensuring high predictive accuracy. Machine Learning models were built with XGBoost algorithm, optimized through Optuna and evaluated based on balanced accuracy, precision, and F1 score metrics. A unique soft-voting ensemble approach further refines the classification process, integrating the strengths of individual models. Validation included extensive testing with active, inactive, and decoy molecules, demonstrating the platform’s efficacy in distinguishing active compounds. AlzyFinder’s innovative approach extends beyond traditional virtual screening by incorporating network pharmacology analysis, thus providing insights into the systemic actions of drug candidates. This feature allows for the exploration of ligand-protein and protein-protein interactions and their extensions, offering a comprehensive view of potential therapeutic impacts. As the first open-access platform of its kind, AlzyFinder stands as a valuable resource for the AD research community, available at http://www.alzyfinder-platform.udec.cl with supporting data and scripts accessible via GitHub https://github.com/ramirezlab/AlzyFinder. In this work as case of study we screened 5 molecules recently reported as active compounds against five key AD targets. We observe that AlzyFinder was able to accurately predict (with a probability greater than 0.70) all five molecules as true positives.

Target Fisher: a Consensus Structure‐Based Target Prediction Tool, and its Application in the Discovery of Selective MAO‐B Inhibitors

Prediction of compound-target interaction using several artificial intelligence algorithms and comparison with a consensus-based strategy

Attention-based approach to predict drug-target interactions across seven target superfamilies

Comprehensive assessment of nine target prediction web services: which should we choose for target fishing?

Target Fishing: A Single-Label or Multi-Label Problem?

In-silico Target Prediction by Ensemble Chemogenomic Model Based on Multi-Scale Information of Chemical Structures and Protein Sequences.

AlzyFinder Platform: A web-based tool for machine-learning based virtual screening and network pharmacology

Predicting novel targets with Bayesian machine learning by integrating multiple biological signatures

ALMERIA: Boosting pairwise molecular contrasts with scalable methods

Finding New Molecular Targets of Familiar Natural Products Using In Silico Target Prediction

Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing.

Machine Learning Scoring Functions for Drug Discoveries from Experimental and Computer-Generated Protein-Ligand Structures: Towards Per-Target Scoring Functions

DeepFusionDTA: drug-target binding affinity prediction with information fusion and hybrid deep-learning ensemble model

Machine learning driven web-based app platform for the discovery of monoamine oxidase B inhibitors

Artificial intelligence for prediction of biological activities and generation of molecular hits using stereochemical information

DrugMGR: a deep bioactive molecule binding method to identify compounds targeting proteins

Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching.

Discovery of Multitarget-Directed Ligands Against Alzheimer'S Disease Through Systematic Prediction of Chemical Protein Interactions

MDTips: A Multimodal-data based Drug-Target interaction prediction system fusing knowledge, gene expression profile and structural data

Prediction of Inhibitory Activity Against the MATE1 Transporter via Combined Fingerprint- and Physics-Based Machine Learning Models

Multimodal contrastive representation learning for drug-target binding affinity prediction